GlassScriptPhysician profile
Hara Berger
NPI 1275964124
$1,057.67
in general payments reported to CMS, 2019-2025
17 companies · $403 in 2025
The $403 reported for 2025 was less than what a typical Endocrinology, Diabetes & Metabolism provider received nationally (typical 2025 total: $506).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $159 · 2020: $35.42 · 2021: $44.84 · 2023: $229 · 2024: $186 · 2025: $403.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $818.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $818.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $236.52 | 2023-2025 | |
| Mayne Pharma Commercial LLC | $185.96 | 2021-2025 | |
| Lilly USA, LLC | $126.40 | 2023-2024 | Jardiance, Zepbound |
| Shire North American Group INC | $119.37 | 2019 | |
| Amgen INC. | $80.58 | 2019-2025 | Evenity, Prolia |
| Novo Nordisk INC | $71.43 | 2021-2024 | Rybelsus, Ozempic, Wegovy |
| Currax Pharmaceuticals LLC | $52.54 | 2020-2025 | Contrave |
| Recordati_rare_diseases_inc. | $26.38 | 2025 | Isturisa |
| Amneal Pharmaceuticals LLC | $23.46 | 2025 | Unithroid |
| Sumitomo Pharma America, INC. | $22.06 | 2023 | Myfembree |
| Hologic Sales and Service, LLC | $18.54 | 2023 | Aptima, Thinprep 2000 Processor |
| Exeltis, USA INC. | $18.46 | 2021 | |
| Corcept Therapeutics | $18.22 | 2023 | Korlym |
| Astellas Pharma US INC | $17.34 | 2023 | Veozah |
| Abbott Laboratories | $15.30 | 2023 | Freestyle Libre 3 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $13.70 | 2019 | |
| Therapeuticsmd, INC. | $11.41 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hara Berger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.